HealthPlans to genetically screen newborns for rare diseases are problematic The UK's health secretary has announced a 10-year plan to check newborns for a huge range of rare conditions. There are major medical and ethical issues with this, argues neurologist Suzanne O'SullivanComment
HealthDrugs like Wegovy can be effective at treating fatty liver disease Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic dysfunction-associated steatohepatitis (MASH) News